Matches in Nanopublications for { ?s ?p "[?-TrCP1 degradation is a novel action mechanism of PI3K/mTOR inhibitors in triple-negative breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- assertion description "[?-TrCP1 degradation is a novel action mechanism of PI3K/mTOR inhibitors in triple-negative breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[?-TrCP1 degradation is a novel action mechanism of PI3K/mTOR inhibitors in triple-negative breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[?-TrCP1 degradation is a novel action mechanism of PI3K/mTOR inhibitors in triple-negative breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[?-TrCP1 degradation is a novel action mechanism of PI3K/mTOR inhibitors in triple-negative breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[?-TrCP1 degradation is a novel action mechanism of PI3K/mTOR inhibitors in triple-negative breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1266590.RAeb8MCp9dIX6ev1rqVpGkBClX8RjzN3qHMQcj1GHzNbI130_assertion description "[?-TrCP1 degradation is a novel action mechanism of PI3K/mTOR inhibitors in triple-negative breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266590.RAeb8MCp9dIX6ev1rqVpGkBClX8RjzN3qHMQcj1GHzNbI130_provenance.
- NP1266592.RAB9UBF1vVj-cY3q6v6BH3A-QPnmOhDDh1QIuOJlo8TP0130_assertion description "[?-TrCP1 degradation is a novel action mechanism of PI3K/mTOR inhibitors in triple-negative breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266592.RAB9UBF1vVj-cY3q6v6BH3A-QPnmOhDDh1QIuOJlo8TP0130_provenance.
- NP1266591.RAtaWHXuU7zlZP-5BOEpm3gMRx594hm2X9FmNuj3UbMGk130_assertion description "[?-TrCP1 degradation is a novel action mechanism of PI3K/mTOR inhibitors in triple-negative breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266591.RAtaWHXuU7zlZP-5BOEpm3gMRx594hm2X9FmNuj3UbMGk130_provenance.
- NP1266593.RAudfPXNNP_miZJn6zrGo-s6T5BQjBHJ-2x4ZeYWbxpgQ130_assertion description "[?-TrCP1 degradation is a novel action mechanism of PI3K/mTOR inhibitors in triple-negative breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266593.RAudfPXNNP_miZJn6zrGo-s6T5BQjBHJ-2x4ZeYWbxpgQ130_provenance.
- NP1266594.RAkMkHJHESbfGAlEQUwbw5POzgllC0Ued_ufEv3UUNOVs130_assertion description "[?-TrCP1 degradation is a novel action mechanism of PI3K/mTOR inhibitors in triple-negative breast cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266594.RAkMkHJHESbfGAlEQUwbw5POzgllC0Ued_ufEv3UUNOVs130_provenance.